Life Sciences Sector BDCs
4 publicly traded Business Development Companies with material exposure to the Life Sciences sector, ranked by live forward dividend yield.
Last updated: 09/04/2026
Ready to Invest in BDCs?
Affiliate Disclosure: Some outbound links on this site route to eToro Partners and Interactive Brokers LLC through internal tracking paths. The site is not currently enrolled in either affiliate program. If accepted into either program in the future, we may earn a commission when you sign up using those links. See our Affiliate Disclosure and Editorial Policy.
To trade high-yield BDCs like ARCC, MAIN, or BXSL, you need a brokerage account that supports fractional shares and real-time distribution tracking. We recommend these institutional partner platforms for retail income investors:
Risk Warning
eToro — U.S. Risk Warning: eToro USA LLC is a US broker-dealer registered with the SEC and a member of FINRA. Investing in stocks involves risk, including the possible loss of principal. Past performance is not an indication of future results. Cryptoassets are unregulated in most US states and are highly volatile. Crypto trading is not available for US residents in all jurisdictions. This communication is for informational purposes only and is not investment advice. See eToro USA risk disclosures at etoro.com.
Interactive Brokers — Risk Warning: Interactive Brokers LLC is a US broker-dealer registered with the SEC and a member of FINRA/SIPC. The risk of loss in online trading of stocks, options, futures, currencies, foreign equities, and fixed income can be substantial. Margin trading is only for experienced investors with high risk tolerance. You may lose more than your initial investment. Past performance is not an indication of future results.
Not Investment Advice: This comparison is for educational and informational purposes only. Nothing here constitutes a recommendation, solicitation, or investment advice to buy or sell any security. Past performance does not guarantee future results. Always conduct your own due diligence and consult a licensed financial advisor.
Dividend Rankings for Life Sciences BDCs
| Rank | Ticker | Name | Dividend Yield | Annual/Share | Frequency | Stock Price |
|---|---|---|---|---|---|---|
| 1 | HRZN | Horizon Technology Finance Corporation | 22.9% | $0.71 | Monthly | $4.84 |
| 2 | TPVG | TriplePoint Venture Growth BDC Corp. | 18% | $0.94 | Quarterly | $5.23 |
| 3 | TRIN | Trinity Capital Inc. | 13.1% | $2.04 | Monthly | $18.22 |
| 4 | HTGC | Hercules Capital, Inc. | 10.7% | $1.86 | Quarterly | $17.63 |
How to Evaluate Life Sciences BDCs
When evaluating life sciences-focused BDCs, prioritize these signals:
- Dividend coverage: NII should comfortably exceed the distribution to indicate sustainability across market cycles.
- Portfolio diversification: Exposure to a single sector concentrates risk; check that the BDC caps any one issuer's weight responsibly.
- NAV stability: A history of stable or rising net asset value signals disciplined underwriting.
- Leverage: Lower leverage ratios cushion sector-specific drawdowns.